Aurigene reports results of AUR101 in phase II study in US patients
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
EC grants conditional marketing authorization based on the EFFISAYIL trial
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
Subscribe To Our Newsletter & Stay Updated